Nondiscrimination Policy Update

Boston Medical Center Health System complies with applicable Federal civil rights laws and does not discriminate on the basis of age, race, color, national origin (including limited English proficiency and primary language), religion, culture, physical or mental disabilities, socioeconomic status, sex, sexual orientation and gender identity and/or expression. BMCHS provides free aids and services to people with disabilities and free language services to people whose primary language is not English.

To read our full Nondiscrimination Statement, click here.

If you have an immunological condition with no known cause, including frequent infections and treatment-resistant autoimmune diseases, the Primary Immunodeficiency Clinic can provide diagnosis and care. Our specialists offer advanced autoimmune testing, immunoglobulin therapy, precision immunomodulatory infusions, and prophylactic treatments, as well as clinical trials. 

Pulmonary, Allergy, Sleep, and Critical Care Medicine (Pulmonology) offers diagnosis, treatment, education, and rehabilitation services for a full range of lung, sleep-related, al…
The CID offers comprehensive services for adults in all areas of infectious diseases, with particular expertise in antibiotic management, HIV/AIDS, STDs, and travel/tropical medic…
We know that managing your medications can be a difficult part of managing your health. At Boston Medical Center, our pharmacy team is here to help.
The Department of Radiology at BMC is a full-service academic medical imaging department that performs over 350,000 screening, diagnostic, and interventional procedures annually f…
Education and Training

Allergy and Immunology Fellowship

Allergy fellows get extensive didactic and hands on training in diagnosis and treatment of patients with a wide range of genetic non-HIV immunodeficiencies. They learn the diagnosis and treatment of non-infectious consequences of immunodeficiency, and the use of replacement therapies. 

Research

Our clinic is a site for clinical trials for therapies of patients with genetic forms of common variable immunodeficiency. We also have a unique research program focused on the non-infectious complications of CVID, which includes the use of inducible pluripotential stem cells from our patients as a source of patient specific immune cells for gene correction and organ involvement.  

Information You May Need